JPWO2020061007A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020061007A5 JPWO2020061007A5 JP2021514531A JP2021514531A JPWO2020061007A5 JP WO2020061007 A5 JPWO2020061007 A5 JP WO2020061007A5 JP 2021514531 A JP2021514531 A JP 2021514531A JP 2021514531 A JP2021514531 A JP 2021514531A JP WO2020061007 A5 JPWO2020061007 A5 JP WO2020061007A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- ligand
- camptothecin
- peg
- camptothecin analogue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732199P | 2018-09-17 | 2018-09-17 | |
| US62/732,199 | 2018-09-17 | ||
| PCT/US2019/051457 WO2020061007A1 (en) | 2018-09-17 | 2019-09-17 | Polymer-based macromolecular prodrugs |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022501341A JP2022501341A (ja) | 2022-01-06 |
| JP2022501341A5 JP2022501341A5 (https=) | 2022-09-26 |
| JPWO2020061007A5 true JPWO2020061007A5 (https=) | 2022-09-26 |
| JP7546552B2 JP7546552B2 (ja) | 2024-09-06 |
Family
ID=69887739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514531A Active JP7546552B2 (ja) | 2018-09-17 | 2019-09-17 | ポリマーベースの高分子プロドラッグ |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US11253603B2 (https=) |
| EP (1) | EP3852793B1 (https=) |
| JP (1) | JP7546552B2 (https=) |
| KR (1) | KR20210072002A (https=) |
| CN (2) | CN119950749A (https=) |
| AU (1) | AU2019344783B2 (https=) |
| CA (1) | CA3112778A1 (https=) |
| EA (1) | EA202190799A1 (https=) |
| MX (1) | MX2021003116A (https=) |
| WO (1) | WO2020061007A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7546552B2 (ja) * | 2018-09-17 | 2024-09-06 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | ポリマーベースの高分子プロドラッグ |
| CN115443947B (zh) * | 2022-10-12 | 2023-11-21 | 江苏省人民医院（南京医科大学第一附属医院） | 高血压动物模型的制备方法 |
| WO2025101904A1 (en) * | 2023-11-08 | 2025-05-15 | The Children's Hospital Of Philadelphia | Norepinephrine transporter-targeted prodrugs for cancer therapy |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999052861A1 (de) * | 1998-04-09 | 1999-10-21 | Institut für Diagnostikforschung GmbH an der Freien Universität Berlin | Neue benzylguanidinderivate für die therapie, in-vivo- und in-vitro-diagnostik |
| JP2002255821A (ja) * | 2001-03-06 | 2002-09-11 | Yakult Honsha Co Ltd | 抗癌剤耐性癌に対する治療剤 |
| US7591994B2 (en) | 2002-12-13 | 2009-09-22 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
| US20040258754A1 (en) * | 2003-06-18 | 2004-12-23 | Valery Alakhov | Compositions for oral administration of camptothecin and its analogs |
| US8394365B2 (en) | 2003-09-17 | 2013-03-12 | Nektar Therapeutics | Multi-arm polymer prodrugs |
| ES2629696T3 (es) | 2003-09-17 | 2017-08-14 | Nektar Therapeutics | Profármacos poliméricos multibrazo |
| BRPI0415858A (pt) * | 2003-10-29 | 2007-01-09 | Sonus Pharma Inc | compostos de medicamentos terapêuticos modificados por tocoferol |
| WO2007106549A2 (en) * | 2006-03-15 | 2007-09-20 | Alza Corporation | Method for treating brain cancer |
| JP2010503706A (ja) * | 2006-09-15 | 2010-02-04 | エンゾン ファーマスーティカルズ インコーポレイテッド | リジン系ポリマーリンカー |
| US20090074074A1 (en) | 2007-06-29 | 2009-03-19 | The Hong Kong University Of Science And Technology | Multiple description encoder and decoder for transmitting multiple descriptions |
| KR101671537B1 (ko) * | 2008-08-11 | 2016-11-01 | 넥타르 테라퓨틱스 | 다분지형 중합체 알카노에이트 컨쥬게이트 |
| HUE047352T2 (hu) | 2008-09-23 | 2020-04-28 | Nektar Therapeutics | Eljárás ütemezett beadásra kamptotecin elõgyógyszerekkel (például PEG-ironotekánnal) |
| CA2738807A1 (en) | 2008-10-21 | 2010-04-29 | Enzon Pharmaceuticals, Inc. | Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| CN101385860B (zh) * | 2008-10-31 | 2011-11-02 | 美国草药泉有限责任公司 | 喜树碱及其衍生物的非线性聚乙二醇前药 |
| US20120171201A1 (en) | 2009-07-22 | 2012-07-05 | Enzon Pharmaceuticals, Inc. | Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| ME03396B (me) | 2009-11-18 | 2020-01-20 | Nektar Therapeutics | Oblici kisele soli konjugata polimer-lek |
| WO2012083197A1 (en) | 2010-12-17 | 2012-06-21 | Nektar Therapeutics | Water-soluble polymer conjugates of topotecan |
| CN102626518B (zh) * | 2012-05-09 | 2014-05-28 | 中国药科大学 | 一种包载难溶性药物的泊洛沙姆/两亲性多糖混合胶束的制备和应用 |
| CN104813167B (zh) | 2012-11-28 | 2019-04-09 | 尼克塔治疗公司 | 用于评估和预测用一种长效拓扑异构酶i抑制剂进行乳腺癌治疗的疗效的方法 |
| US9863949B2 (en) | 2013-05-31 | 2018-01-09 | Nektar Therapeutics | Method for predicting and evaluating responsiveness to cancer treatment with DNA-damaging chemotherapeutic agents |
| DK3052101T3 (da) * | 2013-10-04 | 2019-12-16 | Prolynx Llc | Konjugater af sn-38 med langsom frigivelse |
| US10758614B2 (en) | 2014-06-09 | 2020-09-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services National Institutes Of Health | Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase |
| WO2016040848A1 (en) | 2014-09-12 | 2016-03-17 | G1 Therapeutics, Inc. | Treatment of rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors |
| WO2016050210A1 (zh) | 2014-10-01 | 2016-04-07 | 厦门赛诺邦格生物科技有限公司 | 一种多官能化聚乙二醇衍生物及其制备方法 |
| CN104877127B (zh) | 2015-06-23 | 2017-11-10 | 厦门赛诺邦格生物科技股份有限公司 | 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质 |
| CN107375288B (zh) | 2016-05-16 | 2019-08-23 | 博瑞生物医药（苏州）股份有限公司 | 多臂的聚合靶向抗癌偶联物 |
| US20200163956A1 (en) | 2016-09-06 | 2020-05-28 | Cerebral Therapeutics LLC | Direct brain administration of chemotherapeutics to the csf for patients with primary and secondary brain tumors |
| EP3613792B1 (en) | 2017-04-21 | 2021-02-24 | Bright Gene Bio-Medical Technology Co., Ltd. | Multi-arm targeted anti-cancer conjugate |
| JP7381083B2 (ja) | 2017-09-08 | 2023-11-15 | フォスプラティン テラピューティクス インコーポレイテッド | 免疫調節剤としてのホスファプラチン化合物およびその治療的使用 |
| WO2019090141A1 (en) | 2017-11-02 | 2019-05-09 | Vicus Therapeutics, Llc | Combination drug therapies for cancer and methods of making and using them |
| WO2019222272A1 (en) | 2018-05-14 | 2019-11-21 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
| JP7546552B2 (ja) * | 2018-09-17 | 2024-09-06 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | ポリマーベースの高分子プロドラッグ |
| CN111603567B (zh) | 2019-02-22 | 2024-12-27 | 赣江新区博瑞创新医药有限公司 | Cd44靶向多臂偶联物 |
| CN113811333B (zh) | 2019-05-14 | 2024-03-12 | 诺维逊生物股份有限公司 | 靶向抗癌核激素受体的化合物 |
-
2019
- 2019-09-17 JP JP2021514531A patent/JP7546552B2/ja active Active
- 2019-09-17 CA CA3112778A patent/CA3112778A1/en active Pending
- 2019-09-17 AU AU2019344783A patent/AU2019344783B2/en active Active
- 2019-09-17 KR KR1020217011264A patent/KR20210072002A/ko active Pending
- 2019-09-17 CN CN202510008384.XA patent/CN119950749A/zh active Pending
- 2019-09-17 MX MX2021003116A patent/MX2021003116A/es unknown
- 2019-09-17 EA EA202190799A patent/EA202190799A1/ru unknown
- 2019-09-17 WO PCT/US2019/051457 patent/WO2020061007A1/en not_active Ceased
- 2019-09-17 CN CN201980060783.3A patent/CN112996533B/zh active Active
- 2019-09-17 EP EP19863240.8A patent/EP3852793B1/en active Active
- 2019-09-17 US US16/969,790 patent/US11253603B2/en active Active
-
2022
- 2022-02-11 US US17/670,218 patent/US11642414B2/en active Active
-
2023
- 2023-04-27 US US18/140,289 patent/US12311028B2/en active Active
-
2025
- 2025-05-13 US US19/206,574 patent/US20250387496A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111819217A (zh) | 一种两亲性嵌段共聚物及其制备方法和纳米胶束载药系统 | |
| TWI305538B (https=) | ||
| JP5249016B2 (ja) | タキサン類の高分子結合体 | |
| JP2011528654A5 (https=) | ||
| KR101956444B1 (ko) | 자가 조립 나노입자 방출형 용해성 마이크로니들 구조체 및 그 제조방법 | |
| JP2013545730A5 (https=) | ||
| JP2016528174A5 (https=) | ||
| JP2012503603A5 (https=) | ||
| HK1040052B (zh) | 药物复合物 | |
| CN103044437A (zh) | 用于治疗肿瘤的两亲性缀合物纳米颗粒及制备方法、应用 | |
| US12226523B2 (en) | Method for preparing self-assembled nanoparticle releasing soluble microneedle structure | |
| CN103764172A (zh) | 控释系统 | |
| CN102037058A (zh) | 多西紫杉醇高分子衍生物、及其制造方法及其用途 | |
| JP2013509381A5 (https=) | ||
| EP4700390A3 (en) | Near-infrared cyanine dyes and conjugates thereof | |
| CN102634033A (zh) | 葡聚糖基两亲性嵌段共聚物制备方法 | |
| CN1761485A (zh) | 含略微水溶性抗癌剂和新型嵌段共聚物的胶束制剂 | |
| JP4262090B2 (ja) | 自己凝集体を形成する抗癌剤−キトサン複合体及びその製造方法 | |
| CN1543340A (zh) | 内部包有药物的高分子胶束的冻结干燥用组合物和该胶束的制备方法 | |
| JPWO2020061007A5 (https=) | ||
| KR101874764B1 (ko) | 음이온-양이온성 환형다당류 조성물인 벤다무스틴 | |
| JP2005526016A5 (https=) | ||
| JP4991563B2 (ja) | 胆汁酸−キトサン複合体内部に疎水性抗癌剤が封入された剤形及びその製造方法 | |
| JP2018530568A5 (https=) | ||
| KR101541969B1 (ko) | 단백질 전달용 나노 복합체 및 이의 제조방법 |